2.3. Immunophenotypic Analyses

AT Akihiro Takeshita
NA Norio Asou
YA Yoshiko Atsuta
HF Hiroaki Furumaki
TS Toru Sakura
YU Yasunori Ueda
MS Masashi Sawa
ND Nobuaki Dobashi
YT Yasuhiro Taniguchi
RS Rikio Suzuki
MN Masaru Nakagawa
ST Shigehisa Tamaki
MH Maki Hagihara
KF Katsumichi Fujimaki
HM Hitoshi Minamiguchi
HF Hiroyuki Fujita
MY Masamitsu Yanada
YM Yoshinobu Maeda
NU Noriko Usui
YK Yukio Kobayashi
HK Hitoshi Kiyoi
SO Shigeki Ohtake
IM Itaru Matsumura
TN Tomoki Naoe
YM Yasushi Miyazaki
request Request a Protocol
ask Ask a question
Favorite

Immunophenotypic analyses were performed using bone marrow samples at diagnosis by flow cytometry. Cells were stained with anti-CD45 monoclonal antibody (mAb), gated by CD45 expression and side scatter (SSC), and analyzed by fluorescein conjugated mAb against CD2, CD5, CD7, CD4, CD8, CD19, CD20, CD11b, CD13, CD14, CD15, CD33, CD34, CD56 and HLA-DR antigens. In accordance with the EGIL criteria [28], surface markers generally not determined on APL cells were defined as positive if more than 10% of APL cells expressed the corresponding antigens.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A